| Latest Forum Topics / Trendlines Last:0.061 -- |
 Post Reply
|
|
Time to buy !
|
|||||
|
biper66
Senior |
19-Jan-2026 12:54
|
||||
|
x 0
x 0 Alert Admin |
nice----
|
||||
| Useful To Me Not Useful To Me | |||||
|
piscesmonkey
Supreme |
19-Jan-2026 12:52
|
||||
|
x 0
x 1 Alert Admin |
History high was 395. Now got lion investor should go up 10cents very soon
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
biper66
Senior |
19-Jan-2026 12:48
|
||||
|
x 0
x 0 Alert Admin |
how high can go?
|
||||
| Useful To Me Not Useful To Me | |||||
|
piscesmonkey
Supreme |
19-Jan-2026 12:13
|
||||
|
x 0
x 1 Alert Admin |
https://www.nextinsight.net/story-archive-mainmenu-60/949-2026/16518-trendlines-fresh-capital-including-lion-globals-pours-in-amid-efforts-to-achieve-portfolio-windfalls | ||||
| Useful To Me Not Useful To Me | |||||
|
Stocky901
Supreme |
19-Jan-2026 11:43
|
||||
|
x 0
x 0 Alert Admin |
Yes.. in strong hands.. Lion Global Investors also in Reffles Edu & IX Bio.. 🧐
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Stocky901
Supreme |
19-Jan-2026 11:03
|
||||
|
x 0
x 0 Alert Admin |
Haha queue at 072/071 should be safe 🤔 🧐
|
||||
| Useful To Me Not Useful To Me | |||||
|
newbie1118
Master |
19-Jan-2026 10:44
|
||||
|
x 0
x 0 Alert Admin |
Accumulate. | ||||
| Useful To Me Not Useful To Me | |||||
|
piscesmonkey
Supreme |
19-Jan-2026 10:31
|
||||
|
x 0
x 2 Alert Admin |
Got lion investor inside going up 10cents soon
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Stocky901
Supreme |
19-Jan-2026 10:26
|
||||
|
x 0
x 0 Alert Admin |
Selling down to end soon? Be patient 🧐
|
||||
| Useful To Me Not Useful To Me | |||||
|
piscesmonkey
Supreme |
19-Jan-2026 09:56
|
||||
|
x 0
x 1 Alert Admin |
Bought 73. Lion investor inside
|
||||
| Useful To Me Not Useful To Me | |||||
|
Stocky901
Supreme |
19-Jan-2026 09:44
|
||||
|
x 0
x 0 Alert Admin |
Volumes increasing but still selling down.... buy on dips?.. 🧐 | ||||
| Useful To Me Not Useful To Me | |||||
|
Stocky901
Supreme |
16-Jan-2026 17:48
|
||||
|
x 0
x 1 Alert Admin |
Today volume quite high but still dead. No power to move up.. BBs stopped playing this counter? 🧐
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
biper66
Senior |
15-Jan-2026 17:15
|
||||
|
x 0
x 0 Alert Admin |
tom let us know your gut feel again
|
||||
| Useful To Me Not Useful To Me | |||||
|
eyesontrade
Member |
15-Jan-2026 15:31
|
||||
|
x 0
x 1 Alert Admin |
my gut feeling 1/2 correct now....G Invacom move...
|
||||
| Useful To Me Not Useful To Me | |||||
|
eyesontrade
Member |
15-Jan-2026 15:10
|
||||
|
x 0
x 1 Alert Admin |
At the moment......dead...no power yet
|
||||
| Useful To Me Not Useful To Me | |||||
|
eyesontrade
Member |
15-Jan-2026 10:04
|
||||
|
x 0
x 1 Alert Admin |
Time to watch this counter....Trendline and G Invacom....look like same BB playing...and seems like its goona be playtime very soon | ||||
| Useful To Me Not Useful To Me | |||||
|
longterminvestor
Master |
15-Jan-2026 09:19
|
||||
|
x 0
x 0 Alert Admin |
Special dividends in future? | ||||
| Useful To Me Not Useful To Me | |||||
|
SmallSmall
Supreme |
15-Jan-2026 09:02
|
||||
|
x 0
x 0 Alert Admin |
TRENDLINES: Fresh Capital, Including Lion Global' s, Pours In Amid Efforts To Achieve Portfolio Windfalls15 January 2026
 CEO Haim Brosh is focused on achieving exits for mature portfolio companies under Trendlines.The Israel- and Singapore-based investment group has over 40 medtech and agrifood start-ups, of which a number are mature enough for exits.They have transformed from being early-stage technologies into potentially disruptive and viable businesses that some of the largest corporations are eager to own. As a result, over the past two years, Trendlines' portfolio companies have collectively raised more than US$100 million from external investors. Limaca Medical: A Case Study in Cutting-Edge MedTechThe strength of the Trendlines portfolio is evident in Limaca Medical, for example, which announced a milestone recently. Founded in 2017, it said it had entered into an exclusive U.S. distribution agreement with a global leader in endoscopy equipment. This partnership facilitates a nationwide rollout of the Precision-GI&trade system, supported by FDA 510(k) clearance and CMS Transitional Pass-Through (TPT) payment status, which enables hospitals to claim reimbursements from insurers for the use of this device. For decades, diagnosing gastrointestinal and pancreatic cancers has relied on manual needles. These devices require a physician to manually " stab" a lesion up to 50 times to obtain samples. This often results in fragmented, bloody specimens that are not easy for pathologists to analyze, frequently leading to inconclusive results and delayed treatment. Limaca serves as a case study for the type of high-impact, disruptive technology that is driving investor interest in Trendlines. Phytolon: Revolutionizing the Food Dye IndustryThe US$4 billion global food dye market is at a crossroads.  Phytolon produces colors through fermentation of baker' s yeast to create betalain pigments.Consumers and regulators are rejecting synthetic dyes&mdash often oil-derived subproducts&mdash due to health concerns.While the demand for natural colors is high, traditional plant-based extracts are often unsustainable and inconsistent. Founded in 2018, Phytolon solves this through the " magic" of yeast fermentation. Its process produces efficient, consistent, and sustainable natural pigments. This isn' t just a lab experiment Phytolon has already:
|
||||
| Useful To Me Not Useful To Me | |||||
|
tofudidi
Supreme |
13-Jan-2026 15:35
|
||||
|
x 0
x 0 Alert Admin |
Breakout 80 coming! | ||||
| Useful To Me Not Useful To Me | |||||
|
SmallSmall
Supreme |
13-Jan-2026 15:34
|
||||
|
x 0
x 0 Alert Admin |
Day high $0.077 +$0.002 vol 9.3 mil | ||||
| Useful To Me Not Useful To Me | |||||